Nexalin Technology (NXL) Depreciation & Amortization (CF) (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Depreciation & Amortization (CF) of $4106.0 for Q1 2026, up 3965.35% quarter-over-quarter from $101.0 in Q4 2023.
Nexalin Technology (NXL) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Nexalin Technology's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $4106.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed N/A year-over-year to $4106.0; the TTM figure through Mar 2026 stood at $4106.0 (changed N/A YoY), while the FY2023 annual figure was $503.0, down 5.98% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $4106.0, up from $101.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $4106.0 in Q1 2026, with the low at $101.0 in Q4 2023.
- The 3-year median for Depreciation & Amortization (CF) is $134.0 (2022), against an average of $571.56.
- Peak annual rise in Depreciation & Amortization (CF) reached 0.0% in 2023, while the deepest fall reached 23.48% in 2023.
- Nexalin Technology's Depreciation & Amortization (CF) stood at $132.0 in 2022, then fell by 23.48% to $101.0 in 2023, then soared by 3965.35% to $4106.0 in 2026.
- Business Quant data shows NXL's Depreciation & Amortization (CF) at $4106.0 in Q1 2026, $101.0 in Q4 2023, and $134.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Nexalin Technology | 7.01 Mn | 6.00 Mn | 8,897.00 | 2,738.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,738.00 |
| Jun 30, 2026 | 2,738.00 |
| Mar 31, 2026 | 4,106.00 |
| Mar 31, 2026 | 4,106.00 |
| Dec 31, 2023 | 101.00 |
| Dec 31, 2023 | 101.00 |
| Sep 30, 2023 | 134.00 |
| Sep 30, 2023 | 134.00 |
| Jun 30, 2023 | 134.00 |
| Jun 30, 2023 | 134.00 |
| Mar 31, 2023 | 134.00 |
| Mar 31, 2023 | 134.00 |
| Dec 31, 2022 | 132.00 |
| Dec 31, 2022 | 132.00 |
| Sep 30, 2022 | 135.00 |
| Sep 30, 2022 | 135.00 |
| Jun 30, 2022 | 134.00 |
| Jun 30, 2022 | 134.00 |
| Mar 31, 2022 | 134.00 |
| Mar 31, 2022 | 134.00 |